Yarrow Bioscience (YARW) Change in Account Payables (2017 - 2019)
Yarrow Bioscience's (YARW) quarterly Change in Account Payables came in at $779000.0 in Q4 2019, up 33.16% YoY from $585000.0 in Q4 2018, and up 145.5% on a QoQ basis from -$1.7 million in Q3 2019.
Yarrow Bioscience (YARW) Change in Account Payables (2017 - 2019) Analysis & Trends
Yarrow Bioscience (YARW) has 3 years of Change in Account Payables data on file, last reported at $779000.0 in Q4 2019.
- Quarterly Change in Account Payables rose 33.16% year-over-year to $779000.0 in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $481000.0 (down 41.7% YoY) and the FY2019 annual result came in at $481000.0, down 41.7% from the prior year.
- Change in Account Payables advanced to $779000.0 in Q4 2019, from -$1.7 million in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $1.6 million in Q2 2018 to a low of -$2.4 million in Q3 2018.
- A 3-year average of $160500.0 and a median of $682000.0 in 2018 frame the typical range for Change in Account Payables.
- The widest YoY moves for Change in Account Payables: up 442.9% in 2018, down 256.69% in 2018.
- Tracing YARW's Change in Account Payables over 3 years: stood at -$1.4 million in 2017, then jumped by 142.36% to $585000.0 in 2018, then jumped by 33.16% to $779000.0 in 2019.
- The last three Change in Account Payables figures came in at $779000.0 (Q4 2019), -$1.7 million (Q3 2019), and $921000.0 (Q2 2019), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -8.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 37.53 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Yarrow Bioscience | 31.25 Mn | 8.33 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 779,000.00 |
| Dec 31, 2019 | 779,000.00 |
| Sep 30, 2019 | -1.71 Mn |
| Sep 30, 2019 | -1.71 Mn |
| Jun 30, 2019 | 921,000.00 |
| Jun 30, 2019 | 921,000.00 |
| Mar 31, 2019 | 493,000.00 |
| Mar 31, 2019 | 493,000.00 |
| Dec 31, 2018 | 585,000.00 |
| Dec 31, 2018 | 585,000.00 |
| Sep 30, 2018 | -2.39 Mn |
| Sep 30, 2018 | -2.39 Mn |
| Jun 30, 2018 | 1.59 Mn |
| Jun 30, 2018 | 1.59 Mn |
| Mar 31, 2018 | 1.04 Mn |
| Mar 31, 2018 | 1.04 Mn |
| Dec 31, 2017 | -1.38 Mn |
| Dec 31, 2017 | -1.38 Mn |
| Sep 30, 2017 | 1.52 Mn |
| Sep 30, 2017 | 1.52 Mn |